CMS takes action to lower out of pocket Medicare Part D prescription drug costs

6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to ...

Read more →

Permanent telehealth to strengthen universal Medicare

13 December 2021 - The Australian Government is investing $308.6 million to strengthen Australia’s primary care health system, building on our ...

Read more →

Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies

23 November 2021 - Robert Califf, President Biden’s choice to lead the FDA, earned $2.7 million as an executive at ...

Read more →

Medicare coverage of aducanumab — implications for state budgets

20 November 2021 - CMS is considering whether and under what circumstances Medicare will pay for aducanumab for Alzheimer’s disease.  ...

Read more →

It's time for Congress to get Medicare drug pricing reform right

15 November 2021 - After a three-year debate and delay in delivering patients much-needed relief from high out-of-pocket prescription drug costs, ...

Read more →

Medicare premiums to jump in part due to pricey Alzheimer's drug

12 November 2021 - Seniors on Medicare will have to pay more than $20 more per month extra in premiums ...

Read more →

Democrats revive drug pricing reform with a narrow set of proposed measures

2 November 2021 - On Tuesday 2 November, Senator Schumer announced that an agreement had been reached regarding lowering drug ...

Read more →

Medicare to fund allied health case conferencing

1 November 2021 - New Medicare items will encourage eligible health providers to work together more closely to support the health ...

Read more →

Cystic fibrosis medicine added to PHARMAC's options for investment list

27 October 2021 - PHARMAC has announced that Vertex’s triple combination modulator therapy, known in some countries as Trikafta, has ...

Read more →

Patient and payer incentives to use patented brand name drugs vs authorised generic drugs in Medicare Part D

18 October 2021 - This cross-sectional study of Medicare formulary and pricing data for quarter 3 of 2020 found that most ...

Read more →

European authorities launch HTA network

12 October 2021 - On 29 September, the heads of 19 European HTA authorities met to launch a network for strategic ...

Read more →

NICE guidance on inclisiran should be reconsidered

12 October 2021 - Recommendation is premature without data on cardiovascular outcomes. ...

Read more →

Ban on negotiating Medicare drug prices under pressure

7 October 2021 - Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda. ...

Read more →

Medicare reverses course on decision to universally cover breakthrough medical devices for 4 years

4 October 2021 - In January 2021, in the waning days of the Trump Administration, the CMS finalised a rule ...

Read more →

Medicare bulk billing rates at all time high

18 September 2021 - The latest Medicare data showing that almost nine out of 10 visits to the GP in 2020-21 ...

Read more →